MMIT/Evaluate Acquires Panalgo to Enhance Pharma Analytics Platform

Welsh, Carson, Anderson & Stowe and Hg Combine MMIT and Evaluate to Form Global Pharma Commercial Intelligence Provider

August 20, 2021

Data & Analytics

Welsh, Carson, Anderson & Stowe (WCAS) and Hg have combined Yardley, Pennsylvania-based MMIT and London-based Evaluate into a single, PE-controlled pharmaceutical commercial intelligence business. The merger brings together MMIT’s market-access data and Evaluate’s forecasting and commercial analytics to create a $1.6 billion global provider offering end-to-end insights across the drug life cycle; WCAS and Hg will share joint control of the combined company.

Norstella Formed by Uniting Evaluate, MMIT, Panalgo and The Dedham Group

May 3, 2022

Healthcare Services

Four life‑sciences solutions providers — Evaluate, MMIT, Panalgo and The Dedham Group — have united under the new organization Norstella to combine data, analytics, software and market‑access consulting to speed patient access to therapies. The move creates an integrated platform offering commercial intelligence, market access insights and healthcare analytics to pharmaceutical manufacturers and other life‑sciences customers.

Eden Capital Acquires MITS

July 1, 2019

Software

Eden Capital, a private equity firm focused on technology and business services, acquired MITS, a business-intelligence and analytics provider serving the manufacturing and distribution verticals. MITS will join sister companies Compass Sales Solutions and Tour de Force to integrate CRM, BI/analytics and ERP connectivity, strengthening the combined software platform's capabilities for existing and new customers.

Norstella and Citeline Merge to Create $5B Global Pharma Technology Company

June 28, 2022

Data & Analytics

Norstella (the group of Evaluate, MMIT, Panalgo and The Dedham Group) announced an agreement to merge with Citeline (formerly Pharma Intelligence) to form a combined global pharmaceutical technology and intelligence business valued at about $5 billion. The combination brings clinical trial intelligence, commercial data and real‑world analytics together to offer an end‑to‑end suite of solutions for life sciences companies; the deal involves financial sponsors including Hg (Norstella) and Warburg Pincus (Citeline).

Mastek Acquires BizAnalytica

August 21, 2023

Data & Analytics

Mastek has agreed to acquire BizAnalytica, a Boston-based provider of data cloud and modernization solutions. The acquisition will strengthen Mastek's data services and Generative AI capabilities while expanding its presence and delivery capacity in the US market.

Francisco Partners Acquires IBM's Healthcare Data & Analytics Assets to Launch Merative

June 30, 2022

Data & Analytics

Francisco Partners completed the acquisition of healthcare data and analytics assets from IBM's Watson Health business and launched the standalone company Merative, headquartered in Ann Arbor, Michigan. True Wind Capital and Sixth Street are investing alongside Francisco Partners; IBM sold the assets as part of the carve-out to enable Merative to pursue organic and inorganic growth across life sciences, providers, payers and government health sectors.